Revision history of "Usage of companies for young adults with healthrelated complexness"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 12:13, 1 November 2024Skyhour19 talk contribs 11,663 bytes +11,663 Created page with "1%) of whom received systemic therapy, most commonly with carboplatin-based regimens (n = 357 [86%] patients). The median overall survival was 3.1 months for patients with ADL..."